{{Infobox United States federal proposed legislation| name            = Drug Testing Integrity Act of 2013| fullname        = To prohibit the manufacture, marketing, sale, or shipment in interstate commerce of products designed to assist in defrauding a drug test.| acronym         =| nickname        =| introduced in the = 113th| introduceddate   =| sponsored by    = [[Eliot Engel|Rep. Eliot L. Engel (D, NY-16)]]| number of co-sponsors = 1| public law url  =| cite public law =| cite statutes at large =| acts affected = [[Federal Trade Commission Act]], [[Drug Testing Integrity Act of 2013]], 
| acts repealed   =| title affected   =| sections created =| sections affected = {{USC|15|57a}}, 
| agenciesaffected = [[Federal Trade Commission]]| authorizationsofappropriations =| appropriations =| leghisturl      =| introducedin    = House| introducedbill  = {{USBill|113|hr|1930}}| introducedby    = [[Eliot Engel|Rep. Eliot L. Engel (D, NY-16)]]| introduceddate  = May 9, 2013| committees      = [[United States House Committee on Energy and Commerce]]| passedbody1     =| passeddate1     =| passedvote1     =| passedbody2     =| passedas2       =| passeddate2     =| passedvote2     =| conferencedate  =| passedbody3     =| passeddate3     =| passedvote3     =| agreedbody3     =| agreeddate3     =| agreedvote3     =| agreedbody4     =| agreeddate4     =| agreedvote4     =| passedbody4     =| passeddate4     =| passedvote4     =| signedpresident =| signeddate      =| unsignedpresident =| unsigneddate    =| vetoedpresident =| vetoeddate      =| overriddenbody1 =| overriddendate1 =| overriddenvote1 =| overriddenbody2 =| overriddendate2 =| overriddenvote2 =| amendments      =| SCOTUS cases    =}}++++++++++++++++++++++++++++++




Acts impacted, by reference count:
	2:	Federal Trade Commission Act
	1:	Drug Testing Integrity Act of 2013


Sections impacted, by reference count:
	1:	{{USC|15|57a}}

-30-